Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: 3-methylglutaconic aciduria
3-methylglutaconic aciduria type 1
3-methylglutaconic aciduria (3-MGA) type I is an inborn error of leucine metabolism with a variable clinical phenotype ranging from mildly delayed speech to psychomotor retardation, coma, failure to thrive, metabolic acidosis and dystonia.
This condition has no sub-types.